MTCR
Metacrine, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
David M. Maggio
IPO Date
2020-09-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Metacrine, Inc.
CEO
David M. Maggio
IPO Date
2020-09-16
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 842,211 |
| $0.47 |
| 27 Jan 2023 | York Michael | Chief Business Officer | S-Sale | Disposed | 107,054 | $0.41 |
| 27 Jan 2023 | Klassen Preston | President & CEO | S-Sale | Disposed | 380,605 | $0.41 |
| 21 Dec 2022 | Leonard Braden Michael | director | P-Purchase | Acquired | 120,099 | $0.40 |
| 21 Dec 2022 | Leonard Braden Michael | director | P-Purchase | Acquired | 50,122 | $0.38 |
| 21 Dec 2022 | Leonard Braden Michael | director | P-Purchase | Acquired | 101,384 | $0.40 |
| 9 Nov 2022 | Leonard Braden Michael | director | P-Purchase | Acquired | 39,816 | $0.39 |
| 9 Nov 2022 | Leonard Braden Michael | director | P-Purchase | Acquired | 500 | $0.40 |
| 9 Nov 2022 | Leonard Braden Michael | director | P-Purchase | Acquired | 123,954 | $0.42 |